127
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

PLA-coated Imwitor® 900 K-based herbal colloidal carriers as novel candidates for the intra-articular treatment of arthritis

ORCID Icon, &
Pages 682-692 | Received 12 Nov 2020, Accepted 19 Apr 2021, Published online: 06 May 2021

References

  • Abbas H, Kamel R, EL-Sayed N. 2018. Dermal anti-oxidant, anti-inflammatory and anti-aging effects of Compritol ATO-based resveratrol colloidal carriers prepared using mixed surfactants. Int J Pharm. 541(1–2):37–47.
  • Abdelbary G, Fahmy RH. 2009. Diazepam-loaded solid lipid nanoparticles: design and characterization. Aaps Pharmscitech. 10(1):211–219.
  • Allen KD, Adams SB, JR, Setton LA. 2010. Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model. Tissue Eng Part B Rev. 16(1):81–92.
  • Arora R, Kuhad A, Kaur I, Chopra K. 2015. Curcumin-loaded solid lipid nanoparticles ameliorate adjuvant‐induced arthritis in rats. EJP. 19(7):940–952.
  • Banerjee M, Tripathi L, Srivastava V, Puri A, Shukla R. 2003. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol. 25(2):213–224.
  • Bernardi A, Frozza RL, Meneghetti A, Hoppe JB, Battastini AMO, Pohlmann AR, Guterres SS, Salbego CG. 2012. Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models. Int J Nanomedicine. 7:4927–4942.
  • Bisht K, Wagner K-H, Bulmer AC. 2010. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology. 278(1):88–100.
  • Butler SH, Godefroy F, Besson J-M, Weil-Fugazza J. 1992. A limited arthritic model for chronic pain studies in the rat. Pain. 48(1):73–81.
  • Chandran B, Goel A. 2012. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 26(11):1719–1725.
  • Coradini K, Friedrich RB, Fonseca FN, Vencato MS, Andrade DF, Oliveira CM, Battistel AP, Guterres SS, da Rocha MIUM, Pohlmann AR, et al. 2015. A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies. Eur J Pharm Sci. 78:163–170.
  • Csaki C, Mobasheri A, Shakibaei M. 2009. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1β-induced NF-κB-mediated inflammation and apoptosis. Arthritis Res Ther. 11(6):R165.
  • Curry DJ, Wright DA, Lee RC, Kang UJ, Frim DM. 2004. Surfactant poloxamer 188—related decreases in inflammation and tissue damage after experimental brain injury in rats. J Neurosurg Pediatr. 101:91–96.
  • EL-Ghazaly MA, Fadel NA, Abdel-Naby DH, Abd EL-Rehim HA, Zaki HF, Kenawy SA. 2020. Potential anti-inflammatory action of resveratrol and piperine in adjuvant-induced arthritis: effect on pro-inflammatory cytokines and oxidative stress biomarkers. Egypt Rheumatol. 42(1):71–77.
  • Faham A, Prinderre P, Farah N, Eichler K, Kalantzis G, Joachim J. 2000. Hot-melt coating technology. I. Influence of Compritol® 888 Ato and granule size on theophylline release. Drug Dev Ind Pharm. 26(2):167–176.
  • Fernandes RMSN, DA Silva NP, Sato EI. 2012. Increased myeloperoxidase plasma levels in rheumatoid arthritis. Rheumatol Int. 32(6):1605–1609.
  • Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Sólyom AM, Timmermann BN. 2006. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod. 69(3):351–355.
  • Gerli R, Pitzalis C, Lunardi C. 2002. The role of T cell cytokines in modulating joint inflammation in rheumatoid arthritis. Imaj-Ramat Gan. 4:949–952.
  • Hou D, Xie C, Huang K, Zhu C. 2003. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 24(10):1781–1785.
  • Hunter RL, Luo AZ, Zhang R, Kozar RA, Moore FA. 2010. Poloxamer 188 inhibition of ischemia/reperfusion injury: evidence for a novel anti-adhesive mechanism. Ann Clin Lab Sci. 40(2):115–125.
  • Joe B, Rao UJ, Lokesh BR. 1997. Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Mol Cell Biochem. 169(1–2):125–134.
  • Kamel R, Salama AH, Mahmoud AA. 2016. Development and optimization of self-assembling nanosystem for intra-articular delivery of indomethacin. Int J Pharm. 515(1–2):657–668.
  • Kapoor B, Singh SK, Gulati M, Gupta R, Vaidya Y. 2014. Application of liposomes in treatment of rheumatoid arthritis: quo vadis. Sci World J. 2014:1–17.
  • Lampropoulos C, Orfanos P, Bournia V, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis M, Tzioufas A, Moutsopoulos H, Vlachoyiannopoulos P. 2015. Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. Clin Exp Rheumatol. 33(2):216–224.
  • Lee J, Choi J-Y, Park C. 2008. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm. 355(1–2):328–336.
  • Lefkowitz DL, Lefkowitz SS. 2001. Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited. Immunol Cell Biol. 79(5):502–506.
  • Liu Y-L, Lin H-M, Zou R, Wu J-C, Han R, Raymond LN, Reid PF, Qin Z-H. 2009. Suppression of complete Freund's adjuvant-induced adjuvant arthritis by cobratoxin. Acta Pharmacol Sin. 30(2):219–227.
  • Mollazadeh H, Cicero AF, Blesso CN, Pirro M, Majeed M, Sahebkar A. 2019. Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr. 59(1):89–101.
  • Odobasic D, Yang Y, Muljadi RCM, O'Sullivan KM, Kao W, Smith M, Morand EF, Holdsworth SR. 2014. Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis. Arthritis Rheumatol. 66(4):907–917.
  • Pandey S, Rai N, Rawat P, Ahmad FJ, Talegaonkar S. 2016. Nanofacilitated synergistic treatment for rheumatoid arthritis: a ‘three-pronged’ approach. Med Hypotheses. 92:44–47.
  • Pham CT. 2011. Nanotherapeutic approaches for the treatment of rheumatoid arthritis. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 3(6):607–619.
  • Prosperi D, Colombo M, Zanoni I, Granucci F. 2017. Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases. Semin Immunol. 34:61–67.
  • Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. 1998. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(d,l-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. 15(1):107–119.
  • Rahman HS, Rasedee A, How CW, Abdul AB, Zeenathul NA, Othman HH, Saeed MI, Yeap SK. 2013. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine. 8:2769–2781.
  • Restrepo I, Medina C, Meruane V, Akbari-Fakhrabadi A, Flores P, Rodríguez-Llamazares S. 2018. The effect of molecular weight and hydrolysis degree of poly (vinyl alcohol) (PVA) on the thermal and mechanical properties of poly (lactic acid)/PVA blends. Polímeros. 28(2):169–177.
  • Ribeiro A, Sosnik A, Chiappetta DA, Veiga F, Concheiro A, Alvarez-Lorenzo C. 2012. Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy. J R Soc Interface. 9(74):2059–2069.
  • Riffault M, Six J-L, Netter P, Gillet P, Grossin L. 2015. PLGA-based nanoparticles: a safe and suitable delivery platform for osteoarticular pathologies. Pharm Res. 32(12):3886–3898.
  • Sanmartí R, Ruiz-Esquide V, Hernández MV. 2013. Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches. Curr Top Med Chem. 13(6):698–704.
  • Sayed Aly MN. 2008. Intra-articular drug delivery: a fast growing approach. DDF. 2(3):231–237.
  • Scott DL, Wolfe F, Huizinga TWJ. 2010. Rheumatoid arthritis. Lancet. 376(9746):1094–1108.
  • Shakibaei M, Schulze-Tanzil G, John T, Mobasheri A. 2005. Curcumin protects human chondrocytes from IL-1β-induced inhibition of collagen type II and β1-integrin expression and activation of caspase-3: an immunomorphological study. Ann Anat. 187(5–6):487–497.
  • Silva Rodrigues J, Silva e Silva C, França Muniz T, de Aquino A, Neuza da Silva Nina L, Fialho Sousa N, Nascimento da Silva L, de Souza B, da Penha T, Abreu-Silva A, et al. 2018. Sulforaphane modulates joint inflammation in a murine model of complete Freund’s adjuvant-induced mono-arthritis. Molecules. 23(5):988.
  • Wang Q, Sun X. 2017. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci. 5(8):1407–1420.
  • Wangyang Y, Yi L, Wang T, Feng Y, Liu G, Li D, Zheng X. 2018. MiR-199a-3p inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via suppressing retinoblastoma 1. Biosci Rep. 38(6):1–11.
  • Yan F, Li H, Zhong Z, Zhou M, Lin Y, Tang C, Li C. 2019. Co-delivery of prednisolone and curcumin in human serum albumin nanoparticles for effective treatment of rheumatoid arthritis. Int J Nanomedicine. 14:9113–9125.
  • Yang M, Feng X, Ding J, Chang F, Chen X. 2017. Nanotherapeutics relieve rheumatoid arthritis. J Control Release. 252:108–124.
  • Yi Y, Yoon HJ, Kim BO, Shim M, Kim S-O, Hwang S-J, Seo MH. 2007. A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokinetics. J Control Release. 117(1):59–67.
  • Zewail M, Nafee N, Helmy MW, Boraie N. 2019. Coated nanostructured lipid carriers targeting the joints – an effective and safe approach for the oral management of rheumatoid arthritis. Int J Pharm. 567:118447.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.